COVID-19 Impact on Quest Diagnostics Inc.s Revenue and Operations (Medical Devices)

COVID-19 Impact on Quest Diagnostics Inc.s Revenue and Operations (Medical Devices)



Quest Diagnostics provides diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. Quest Diagnostics offers a comprehensive range of services including clinical testing with gene-based and other esoteric tests, anatomic pathology services, life insurer services, clinical trial testing, healthcare information technology and diagnostic products. The report, COVID-19 Impact on Quest Diagnostics Inc.s Revenue and Operations (Medical Devices) presents a deep dive analysis into how Quest Diagnostics is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Deep dive analysis into how Quest Diagnostics Inc. is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Key Highlights

- Net sales for Q3 2020 increased by 42.5% from 2019, despite providing approximately 40% of all commercial diagnostic COVID-19 testing in the US with its Quest SARS-CoV-2 rRT-PCR Test that received FDA emergency use authorization on March 17, 2020.
- Quest Diagnostics’ results in January and February were consistent with its earlier-provided full-year guidance. However, during the last two weeks of March, volumes declined over 40%, even with COVID-19 testing.
- Recently, Quest Diagnostics has partnered with Centene to distribute 25,000 Quest COVID-19 test kits every week to Federally Qualified Health Centers. Quest Diagnostics has also started offering COVID-19 antibody testing using Abbott’s and EUROIMMUN’s tests.

Scope

The report provides a comprehensive analysis of the impact of COVID-19 on Quest Diagnostics Inc. -
- It provides insights on Quest Diagnostics Inc.s exposure to the regions and businesses impacted by the COVID-19 outbreak.
- It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.

Reasons to Buy

- An overview of how Quest Diagnostics Inc. will be affected by the COVID-19 pandemic.


COVID-19 impact analysis on Quest Diagnostics Inc. - Key Findings
Quest Diagnostics Inc. Key Facts
Geographic spread analysis - COVID-19 vs Quest Diagnostics Inc.. sales
The impact of COVID-19 on regional GDP per capita levels
Quest Diagnostics Inc. exposure: revenues by region and market vs regional impact levels
Quest Diagnostics Inc. : revenue impact by region and market for 2020
Operational reactions from Quest Diagnostics? Indications from recruitment trends
Operational reactions from Quests Indications from US pricing trends
Contact us


Reconstruction Meshes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Reconstruction Meshes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)Reconstruction Meshes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to

USD 7500 View Report

Disposable Endoscopes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Disposable Endoscopes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)Disposable Endoscopes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to

USD 7500 View Report

Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 Update

Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 UpdateThis 62-page PowerPoint based report gives an important update to the previous year with an expert analysis on how COVID-19 is

USD 1495 View Report

Global Peptide Therapeutics Market (2021 Edition) – Analysis By Drug Type (Generic, Innovative), Manufacturing Type (In-House, Outsourced), Application,, By Region, By Country: Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)

Executive The Global Peptide Therapeutics Market is valued at USD 32.1 Billion in the year 2020. The growth of Peptide Therapeutics is directly associated with drug development. New drug discovery

USD 2400 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available